Cargando…
Use of non-selective B-blockers is safe in hospitalised decompensated cirrhosis patients and exerts a potential anti-inflammatory effect: Data from the ATTIRE trial
BACKGROUND: Nonselective B-blockers (NSBBs) are believed to have pleiotropic effects beyond reducing portal pressure. However, studies also report potential harm in patients hospitalized with cirrhosis and ascites. We therefore investigated whether NSBB use at ATTIRE trial entry (Albumin to prevent...
Autores principales: | Tittanegro, Thais, China, Louise, Forrest, Ewan, Kallis, Yiannis, Ryder, Stephen D., Wright, Gavin, Freemantle, Nick, O'Brien, Alastair |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9672423/ https://www.ncbi.nlm.nih.gov/pubmed/36407574 http://dx.doi.org/10.1016/j.eclinm.2022.101716 |
Ejemplares similares
-
Evaluating the Role of Antibiotics in Patients Admitted to Hospital With Decompensated Cirrhosis: Lessons From the ATTIRE Trial
por: Kutmutia, Rishen, et al.
Publicado: (2023) -
Targeted Albumin Infusions Do Not Improve Systemic Inflammation or Cardiovascular Function in Decompensated Cirrhosis
por: China, Louise, et al.
Publicado: (2022) -
Monocyte dysfunction in decompensated cirrhosis is mediated by the prostaglandin E2-EP4 pathway
por: Maini, Alexander A., et al.
Publicado: (2021) -
Parenclitic Network Mapping Identifies Response to Targeted Albumin Therapy in Patients Hospitalized With Decompensated Cirrhosis
por: Oyelade, Tope, et al.
Publicado: (2023) -
ATTIRE: Albumin To prevenT Infection in chronic liveR failurE: study protocol for an interventional randomised controlled trial
por: China, Louise, et al.
Publicado: (2018)